ArticleCureus2024
Anti-inflammatory and Antioxidant Activity of Neem and Kirata-Induced Silver Nanoparticles Against Oral Biofilm: An In Vitro Study.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Comprehensive Review of Silver Nanoparticles in Food Packaging Applications.International journal of molecular sciences · 2025Review
- Structural and morphological characterization of silver nanoparticles intruded mineral trioxide aggregate admixture as a chair-side restorative medicament: an in vitro experimental study.Restorative dentistry & endodontics · 2025Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Silver nanoparticles have been the most commonly used nanoparticles which could be integrated with plant extracts. The mutually beneficial interaction between neutral plant extracts and nanoparticles reduced the chemical toxicity while promoting synthesis. Azadirachta indica, widely known as the neem plant, has diverse medicinal compounds encompassing antibacterial, antiviral, antiprotozoal, insecticidal, antifungal, and antioxidant properties. Swertia chirata, known as Chirayata in India, stands out for its dual roles as a laxative and appetiser with pronounced antimicrobial and anti-inflammatory qualities. Hence, this study aimed to evaluate the anti-inflammatory and antioxidant properties of silver nanoparticles synthesized using Neem and Kirata extract. Materials and methods The plant extracts of Neem (Azadirachta indica) and Kirata (Swertia chirata) were obtained in powder form. It was later formulated into an extract and stored in a refrigerator at 4 degrees Celsius. The formulated extract of Neem and Kirata was then incorporated with silver nitrate to form a modified silver nanoparticle using a green synthesis approach. The anti-inflammatory activity of Neem and Kirata extract was tested using Bovine Serum Assay and Egg Albumin Assay. The antioxidant activity of the new herbal-formulated Ag nanoparticles was determined by the DPPH ((2,2-diphenyl-1-picrylhydrazyl) assay. Results Based on the anti-inflammatory assays, the Neem and Kirata-induced nanoparticles showed increasing levels of inhibition, while the standard showed slightly higher inhibition at 10, 20 and 30 µL. At 40 µL and 50 µL, both Kirata and Neem (Ag) and the standard showed high levels of inhibition, nearing 75% and above, with the standard consistently showing a marginally higher inhibition percentage. Based on the DPPH assay, the Neem Kirata-induced Ag nanoparticle showed a comparable or slightly higher inhibition percentage compared to the standard. Conclusion The study underscores the potential of Neem and Kirata herbal-based silver nanoparticles as effective anti-inflammatory and antioxidant agents. Future research directions should focus on refining nanoparticle synthesis, investigating mechanisms of action, and exploring additional therapeutic applications in the biomedical and pharmaceutical sectors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.